Penny CL, Quow K, Rundle CW, Al-Rohil RN, et al. Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin' :reply from authors. Br J Dermatol 2022 Mar 10. doi: 10.1111/bjd.21239.
PMID: 35266142